Meghan is a Chambers-ranked partner in our antitrust, competition and trade practice, based in Washington, DC. Meghan represents clients in merger investigations before the Department of Justice (DOJ) and the Federal Trade Commission (FTC).
In addition to her merger investigations practice, Meghan counsels clients on a range of antitrust issues, including competitor collaborations, joint ventures, all aspects of vertical relationships, and contractual arrangements.
Meghan has experience across industries on complex and high-stakes antitrust issues. Meghan is known for her ability to become fully immersed in her clients’ businesses, for providing highly tailored commercial advice, and for translating technical subjects into plain language to appeal to businesspeople and regulators alike.
Meghan is a leader in the American Bar Association's Section of Antitrust Law through her role as an editor of the forthcoming 10th edition of the Antitrust Law Developments treatise. Previously she served as a Co-Chair of the Mergers and Acquisitions Committee. Early in her career, Meghan clerked for the Honorable Jane R. Roth of the US Court of Appeals for the Third Circuit.
Her firm service includes leading the US Associate Talent Development Committee. Outside of the firm, Meghan serves as an Additional Trustee for Beauvoir School to the Protestant Episcopal Cathedral Foundation Board of Trustees in Washington, DC.
Meghan has been recognized for her client service by leading industry publications including Chambers USA, Legal 500, Who’s Who Legal, and Lawdragon 500.
- Standard BioTools Inc. in the pending sale of its SomaLogic business to Illumina, Inc. for $425mn in cash and milestone payments.
- Lowe’s Companies, Inc. in its $8.8bn acquisition of Foundation Building Materials.
- Celsius Holdings, Inc. on its $1.8bn acquisition of Alani Nutrition LLC and its $585mn acquisition of the Rockstar Energy brand in the US and Canada and associated agreements.
- CrowdStrike, Inc. on its $290mn acquisition of Onum and its $260mn acquisition of Pangea.
- Cencora, Inc. on its $4.6bn acquisition of Retina Consultants of American (RCA).
- ServiceNow on its $475mn acquisition of Logik.ai and its joint $1.5bn investment, alongside Salesforce, in Genesys.
- Bio-Rad on its binding offer to acquire the all equity interest in French Digital PCR Developer Stilla Technologies.
- Prysmian, S.p.A. on its $950mn acquisition of Channell Commercial Corporation.
- Johnson & Johnson on its $850mn acquisition of Proteologix, Inc.and its $2bn acquisition of Ambrx Biopharma.
- Janssen Pharmaceutical on its (i) global collaboration and licensing agreements with Cellular Biomedicine Group (CBMG), valued at $245mn; (ii) global licensing, co-development, and commercialization agreement with Nanobiotix, valued at up to $1.8bn; and (iii) out-license Co-development, Co-commercialization, and License Agreement with Sanofi Pasteur, Inc., valued at $175mn.
- Zeus Company, a medical device company, on its sale to EQT Partners.
- PhenomeX, a provider of single-cell biology research tools, in its $108mn sale to Bruker.
- Roivant Sciences on its $7.1bn sale of Telavant to Roche and its up to $1.2bn sale of Dermavant to Organon.
- eBay on its transactions with Collectors Universe Inc. to acquire Goldin Auctions LLC and to sell the eBay vault; and its $295mn acquisition of TCGplayer.
- JD Sports on its $1.1bn acquisition of Hibbett, Inc.; its $495mn acquisition of DTLR Villa; and its $325mn acquisition of Shoe Palace.
- Ericsson on its $6bn acquisition of Vonage and its divestiture of its internet of things and connected vehicle cloud business to Aeris.
- Verizon in its $5bn sale of Verizon Media Group to Apollo.
- Aerojet Rocketdyne in its proposed $4.4bn sale to Lockheed Martin (abandoned due to regulatory concerns).
- A chemical company on its divestiture of its kaolin clay business to KaMin, Inc.; its $1.2bn divestiture of its pigments business to Sun Chemical Company/DIC; and its $2.7bn water and paper chemicals transaction with Solenis.
- Western Union on the $910mn sale of its B2B global payments business to Goldfinch Partners and The Baupost Group.
- Amcor plc on its $6.8bn acquisition of Bemis Company.
- Change Healthcare on its $3.4bn JV with McKesson Technology Solutions.
- Orbital Sciences Corporation on its $5bn merger of equals with Alliant Techsystems (ATK).
700 13th Street, NW
10th Floor